Featured White Papers
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- PCI DSS therapy for the smaller retailer (McAfee)
- The rise of Web commuting (Citrix Online)
Content provided in partnership with
Gm Insulin Alert - Brief Article
Ecologist, The, April, 2000
Genetically modified insulin, long the darling of the biotechnology industry, is being linked to adverse health effects. The insulin, which uses e-coli bacteria to create a synthetic 'human' insulin, is taken by thousands of diabetics every day. But medical experts have linked the GM product to potential increased incidence of hypoglycaemic comas, which can be fatal.
Many diabetics also claim that the symptoms that would normally warn them of an oncoming attack disappear when they take synthetic insulin. Although producers Danish Novo Nordisk and VS giant Elli Lilly deny these allegations, British diabetic specialists say that up to 20 per cent of diabetics could be suffering adverse reactions to the GM insulin.
COPYRIGHT 2000 MIT Press Journals
COPYRIGHT 2001 Gale Group
